The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

about

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

Item

http://www.wikidata.org/entity/Q51746289

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@en

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@nl

type

Item

label

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@en

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@nl

prefLabel

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@en

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@nl

P1476

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors.

@en

P2093

Marie Ito

http://www.w3.org/2001/XMLSchema#string

Tetsuhiro Tanaka

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Renal effects of dapagliflozin in patients with type 2 diabetes

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys

Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury

Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats

Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

The proximal tubule in the pathophysiology of the diabetic kidney.

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.

Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.

P31

scholarly article

review article

P356

10.2169/INTERNALMEDICINE.9842-17

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29491318

http://www.w3.org/2001/XMLSchema#string

P921

maturity-onset diabetes of the young

P932

6120824

http://www.w3.org/2001/XMLSchema#string